The Biorenewable Deployment Consortium (BDC) honored Green Biologics Inc., the U.S. subsidiary of Green Biologics Ltd., a U.K. industrial biotechnology and renewable specialty chemicals company, with the organization’s Spring 2017 Commercialization Achievement Award at a meeting in Des Moines, Iowa, on May 2, 2017.
BioAmber Inc. announced that its shares of common stock (Common Shares) have been conditionally approved for listing on the Toronto Stock Exchange (TSX) and that its previously issued special warrant (the Special Warrant) has been automatically exercised.
Green Biologics Inc., the U.S. subsidiary of Green Biologics Ltd., a U.K. industrial biotechnology and renewable chemicals company, was named the No. 12 hottest company in this year’s 50 Hottest Companies in the Advanced Bioeconomy (Hot 50).
At the 2017 General Assembly held on February 15, 2017, the Bio-based Industries Consortium (BIC) welcomed 16 new Full members and 22 new Associate members, signaling strong European cooperation on the bio-economy.
Green Biologics Inc. announced an exclusive collaboration with Jungbunzlauer Ladenburg GmbH, the German operating unit of Jungbunzlauer Suisse AG in Basel, Switzerland.
Green Biologics Inc., the U.S. subsidiary of UK-based Green Biologics Ltd., has been named to the 2017 Global Cleantech 100 and recognized in the 2016 Global Clean Energy Awards as the Best Renewable Specialty Chemical Company – UK.
